Deciphera Pharmaceuticals, Inc. (DCPH)

NASDAQ: DCPH · IEX Real-Time Price · USD

25.38

+0.01 (0.04%)

At close: May 7, 2024, 4:00 PM

25.31

-0.07 (-0.28%)

Pre-market: May 8, 2024, 7:00 AM EDT

Deciphera Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015
Cash & Equivalents	83.51	64.74	87.06	135.9	120.32	293.76	196.75	57.46	25.78
Short-Term Investments	222.71	259.75	198.57	416.03	459.26	0	0	0	0
Cash & Cash Equivalents	306.22	324.49	285.63	551.93	579.58	293.76	196.75	57.46	25.78
Cash Growth	-5.63%	13.60%	-48.25%	-4.77%	97.29%	49.31%	242.41%	122.92%	-
Receivables	31.95	22.43	20.6	13.9	0	0	0	0	0
Inventory	21.21	20.56	14.13	5.72	0	0	0	0	0
Other Current Assets	21.72	25.48	18.66	12.49	13.83	7.27	1.43	0.79	0.61
Total Current Assets	381.1	392.96	339.01	584.03	593.41	301.04	198.18	58.25	26.38
Property, Plant & Equipment	37.49	43.25	45.41	45.92	27.49	13.45	0.84	0.51	0.39
Long-Term Investments	54.98	17.83	45.06	12.48	1.51	1.07	0	0	0
Other Long-Term Assets	0	0	0	0	0	0	0.08	0.18	0.02
Total Long-Term Assets	92.47	61.08	90.47	58.4	29	14.52	0.91	0.69	0.41
Total Assets	473.57	454.04	429.48	642.43	622.41	315.56	199.1	58.95	26.79
Accounts Payable	26.48	18.61	13.13	12.31	19.58	8.31	4.4	1.41	1.6
Current Debt	3.5	3.24	2.87	2.46	1.75	0.73	0.19	0.19	0.19
Other Current Liabilities	70.3	64.62	80.77	55.23	38.72	13.71	9.23	2.96	1.26
Total Current Liabilities	100.28	86.47	96.77	69.99	60.04	22.74	13.82	4.56	3.05
Long-Term Debt	22.38	25.88	27.99	28.76	15.9	12.45	1.29	1.48	1.68
Other Long-Term Liabilities	0	0	0	0	0	0.38	0.01	0	0
Total Long-Term Liabilities	22.38	25.88	27.99	28.76	15.9	12.84	1.31	1.48	1.68
Total Liabilities	122.65	112.35	124.76	98.76	75.94	35.58	15.12	6.04	4.73
Total Debt	25.88	29.11	30.86	31.22	17.65	13.18	1.48	1.67	1.87
Debt Growth	-11.11%	-5.66%	-1.15%	76.88%	33.92%	789.94%	-11.21%	-10.61%	-
Retained Earnings	-1,428.31	-1,233.36	-1,054.43	-754.47	-487.98	-295.72	-195.87	-145.59	-119.65
Comprehensive Income	0.58	-0.98	0.05	0.01	0.11	0	0	0	0
Shareholders' Equity	350.92	341.69	304.72	543.68	546.47	279.98	183.97	-139.76	-115.31
Net Cash / Debt	280.34	295.37	254.77	520.71	561.93	280.58	195.27	55.79	23.91
Net Cash / Debt Growth	-5.09%	15.94%	-51.07%	-7.33%	100.27%	43.69%	250.00%	133.34%	-
Net Cash Per Share	3.30	3.91	4.39	9.33	13.11	7.93	11.63	4.80	5.63
Working Capital	280.82	306.49	242.24	514.04	533.37	278.29	184.37	53.7	23.33
Book Value Per Share	4.13	4.53	5.25	9.75	12.75	7.91	10.96	-12.02	-27.16

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).